SUYASH PRASAD Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for SUYASH PRASAD.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of SUYASH PRASAD. SUYASH PRASAD is a Senior VP & Chief Med Officer in Audentes Therapeutics, Inc. ($BOLD) and a CMO and Head of R&D in Taysha Gene Therapies, Inc. ($TSHA).
Address: C/O AUDENTES THERAPEUTICS, INC. 600 CALIFORNIA STREET, 17TH FLOOR SAN FRANCISCO 94108 CA
Companies in which SUYASH PRASAD is an Insider
Audentes Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of SUYASH PRASAD: Senior VP & Chief Med Officer
Holdings: 17,479 shares
Current Value: $276,693
Latest Transaction: Jun 07 2019
$BOLD Market Capitalization: $337.82M
$BOLD Previous Close: $15.83
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Taysha Gene Therapies, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of SUYASH PRASAD: CMO and Head of R&D
Holdings: 672,589 shares
Latest Transaction: Jan 20 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of SUYASH PRASAD
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 20 2021 | TSHA | Taysha Gene Therap ... | PRASAD SUYASH | CMO and Head of R&D | Option Exercise | A | 31.00 | 80,000 | 2,480,000 | 80,000 | |
| Sep 30 2020 | TSHA | Taysha Gene Therap ... | PRASAD SUYASH | CMO and Head of R&D | Option Exercise | C | 0.00 | 3,529 | 0 | 0 | |
| Sep 30 2020 | TSHA | Taysha Gene Therap ... | PRASAD SUYASH | CMO and Head of R&D | Buy | C | 0.00 | 3,844 | 0 | 672,589 | 668.7 K to 672.6 K (+0.57 %) |
| Sep 30 2020 | TSHA | Taysha Gene Therap ... | PRASAD SUYASH | CMO and Head of R&D | Option Exercise | C | 0.00 | 3,529 | 0 | 0 | |
| Sep 30 2020 | TSHA | Taysha Gene Therap ... | PRASAD SUYASH | CMO and Head of R&D | Buy | C | 0.00 | 3,844 | 0 | 672,589 | 668.7 K to 672.6 K (+0.57 %) |
| Sep 25 2020 | TSHA | Taysha Gene Therap ... | PRASAD SUYASH | CMO and Head of R&D | Grant | A | 0.00 | 668,745 | 0 | 668,745 | 0 to 668.7 K |
| Jun 07 2019 | BOLD | Audentes Therapeut ... | PRASAD SUYASH | Senior VP & Chief M ... | Payment of Exercise | F | 37.31 | 757 | 28,244 | 17,479 | 18.2 K to 17.5 K (-4.15 %) |